Metraipolis › archive › dc_dffbe287afad

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies — Europe PMC PMID:41698968

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41698968
DOI: 10.1038/s41598-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-05T19:02:15.099Z
SHA-256 of the archived text: e0f95b4dd24af9a2d5d461c88f1fd93589c9148ded17bd524fd4a3f04d64833d
Stable URL of this page: https://metraipolis.com/documento/dc_dffbe287afad

How to cite

Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies — Europe PMC PMID:41698968 — Europe PMC (en), https://europepmc.org/article/MED/41698968 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dffbe287afad (Metraipolis archive dc_dffbe287afad, sha256 e0f95b4dd24af9a2d5d461c88f1fd93589c9148ded17bd524fd4a3f04d64833d)

BibTeX

@misc{dcdffbe287afad,
  title = {Development and validation of a PSMA-positive triple-negative breast cancer mouse model for preclinical targeted radionuclide therapies — Europe PMC PMID:41698968},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41698968},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dffbe287afad; sha256 e0f95b4dd24af9a2d5d461c88f1fd93589c9148ded17bd524fd4a3f04d64833d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41698968. Agents can read the archived copy with the MCP tool read_document.